PDA Responds to the Novel Coronavirus Situation.

Johnson, Richard M

Johnson, Richard M.

Johnson RM; President and CEO, Parenteral Drug Association Bethesda, MD, USA johnson@pda.org.

PDA J Pharm Sci Technol ; 74(2): 170, 2020.

Article in English | MEDLINE | ID: covidwho-50288

Subject(s)

Coronavirus Infections; Pandemics; Pharmaceutical Preparations/administration & dosage; Pneumonia, Viral; Societies, Pharmaceutical; Betacoronavirus/pathogenicity; COVID-19; Congresses as Topic; Coronavirus Infections/immunology; Coronavirus Infections/transmission; Coronavirus Infections/virology; Host-Pathogen Interactions; Humans; Infusions, Parenteral; Pneumonia, Viral/immunology; Pneumonia, Viral/transmission; Pneumonia, Viral/virology; SARS-CoV-2; Travel

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Societies, Pharmaceutical / Pharmaceutical Preparations / Coronavirus Infections / Pandemics Limits: Humans Language: English Journal: PDA J Pharm Sci Technol Journal subject: Pharmacy / Pharmacology Year: 2020 Document Type: Article Affiliation country: Pdajpst.2019.001118

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google